Ricardo R. Bergo
Pocos De Caldas, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Safety and outcomes of dapagliflozin initiation in critically ill patients with acute kidney injury: A post-hoc analysis of the defender trial.
Journal: Journal of critical care
Published: December 17, 2025
Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes.
Journal: The New England journal of medicine
Published: September 01, 2025
Dapagliflozin in Acute Cardiovascular Conditions: Insights From the DEFENDER Trial.
Journal: JACC. Advances
Published: July 15, 2025
Effects of dapagliflozin on urinary output, fluid balance, and biochemistry in critically ill patients: a post-hoc secondary analysis of the DEFENDER trial.
Journal: Critical care (London, England)
Published: April 21, 2025
Primary results of the brazilian registry of atherothrombotic disease (NEAT).
Journal: Scientific reports
Published: September 12, 2023
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: June 12, 2023
Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.
Journal: Critical care science
Published: May 26, 2023
Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial.
Journal: Circulation. Cardiovascular interventions
Published: April 11, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026